COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Heidelberg Pharma: New Clinical Data on Lead ADC Candidate HDP-101 Presented at IMS 2024 Demonstrating Complete Remission in One Patient
Heidelberg Pharma presents new clinical data on lead ADC candidate HDP-101 at IMS 2024, showing complete remission in one patient. Company developing innovative ADCs for cancer treatment -
COMMUNIQUÉ DE PRESSE
SMT Scharf AG requests change of stock ticker symbol
SMT Scharf AG requests change of stock ticker symbol from 'S4AA' to 'S188' effective October 02, 2024, for trading on Frankfurt Stock Exchange. Company specializes in underground mining transport solutions and logistics systems -
-
-
COMMUNIQUÉ DE PRESSE
Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research GmbH releases an update on Formycon AG, with analyst Simon Scholes reiterating a BUY rating and raising the price target from EUR 80 to EUR 82. The approval of the biosimilar FYB202 in the EU and US contributes to the positive outlook on Formycon's market share prospects -
COMMUNIQUÉ DE PRESSE
VAZIVA SA: Invitation webinaire actionnaires individuels le mardi 15 octobre 2024 dans le cadre de la publication des Résultats semestriels 2024
VAZIVA SA invite les actionnaires individuels à un webinaire le 15 octobre 2024 pour présenter les Résultats semestriels 2024 et la stratégie de développement -
-
-
COMMUNIQUÉ DE PRESSE
Fifth exit in 2024: Mutares has signed an agreement to sell MobiLitas to Savina for a purchase price in the single-digit million range
Mutares SE & Co. KGaA has signed an agreement to sell MobiLitas to Savina in the single-digit million range, focusing on core business GoCollective in Denmark. Mutares is a listed private equity holding company with significant operational improvement potential
